Low Prevalence of Thrombosis Prophylaxis Dose Adjustments Highlights Implications for Patient Safety

Background: Pharmacologic thromboprophylaxis (PTP) is the mainstay prevention strategy for venous thromboembolism (VTE). PTP agents traditionally dosed, like unfractionated heparin (UFH) and enoxaparin (ENOX), are associated with failure and bleeding in obese and underweight patients, respectively....

Descripción completa

Detalles Bibliográficos
Autores principales: Anthony Hawkins, W., Smith, Susan E., Stitt, Tia M., Abdulla, Aliya, Branan, Trisha N., Hall, Ronald G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: University of Minnesota Libraries Publishing 2021
Materias:
Idea Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9401384/
https://www.ncbi.nlm.nih.gov/pubmed/36033114
http://dx.doi.org/10.24926/iip.v12i4.4288

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9401384/
https://www.ncbi.nlm.nih.gov/pubmed/36033114
http://dx.doi.org/10.24926/iip.v12i4.4288

Ejemplares similares